Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BARDA
Pharma
Regeneron to collect $270M in renewed US Ebola drug supply deal
Regeneron is re-upping a supply pact for its approved Ebola treatment Inmazeb to the U.S. government, in a deal worth some $270 million.
Fraiser Kansteiner
Oct 27, 2026 9:28am
BARDA hands Kaléo $96M contract for chemical threat preparedness
Oct 13, 2026 11:02am
Shionogi sets sights on US antibiotic plant with $119M from BARDA
Apr 8, 2026 2:14pm
Fierce Biotech
HHS launches $100M prize to develop antiviral therapies
Feb 3, 2026 4:00pm
FDA signs off on expansion for GSK's Blujepa to treat gonorrhea
Dec 12, 2025 10:30am
Cidara snares BARDA award to boost R&D, production of flu asset
Oct 3, 2025 10:10am